Development of a comorbidity index for use in obstetric patients.
Brian T. Bateman,Jill M. Mhyre,Sonia Hernandez-Diaz,Krista F. Huybrechts,Michael A. Fischer,Andreea A. Creanga,William M. Callaghan,Joshua J. Gagne +7 more
Reads0
Chats0
TLDR
This new maternal comorbidity index provides a simple measure for summarizing the burden of maternal illness for use in the conduct of epidemiologic, health services, and comparative effectiveness research.About:
This article is published in Obstetrics & Gynecology.The article was published on 2013-11-01 and is currently open access. It has received 308 citations till now. The article focuses on the topics: Comorbidity & Severity of illness.read more
Citations
More filters
Journal ArticleDOI
Antipsychotic Use in Pregnancy and the Risk for Congenital Malformations
Krista F. Huybrechts,Sonia Hernandez-Diaz,Elisabetta Patorno,Rishi J. Desai,Helen Mogun,Sara Z. Dejene,Jacqueline M. Cohen,Alice Panchaud,Lee S. Cohen,Brian T. Bateman +9 more
TL;DR: Evidence from this large study suggests that use of APs early in pregnancy generally does not meaningfully increase the risk for congenital malformations overall or cardiac mal Formations in particular.
Journal ArticleDOI
Lithium Use in Pregnancy and the Risk of Cardiac Malformations.
Elisabetta Patorno,Krista F. Huybrechts,Brian T. Bateman,Jacqueline M. Cohen,Rishi J. Desai,Helen Mogun,Lee S. Cohen,Sonia Hernandez-Diaz +7 more
TL;DR: Maternal use of lithium during the first trimester was associated with an increased risk of cardiac malformations, including Ebstein's anomaly; the magnitude of this effect was smaller than had been previously postulated.
Journal ArticleDOI
Racial and ethnic disparities in severe maternal morbidity prevalence and trends
TL;DR: The prevalence of SMM varied considerably by race/ethnicity but increased at similarly high rates among all racial/ethnic groups, which remained persistent over time.
Journal ArticleDOI
Validation of an obstetric comorbidity index in an external population.
Amy Metcalfe,Lisa M. Lix,Johnson Ja,Gillian Currie,Andrew W. Lyon,Francois P. Bernier,Suzanne Tough +6 more
TL;DR: This study aimed to externally validate this index and to examine the impact of including hospitalisation/delivery records only when estimating comorbidity prevalence and discriminative performance of the obstetric comorbridity index.
Journal ArticleDOI
Rural-Urban Differences In Severe Maternal Morbidity And Mortality In The US, 2007–15
TL;DR: It is found that severe maternal morbidity and mortality increased among both rural and urban residents in the study period, and when controlled for sociodemographic factors and clinical conditions, rural residents had a 9 percent greater probability of severe maternal mortality, compared with urban residents.
References
More filters
Journal ArticleDOI
A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation☆
TL;DR: The method of classifying comorbidity provides a simple, readily applicable and valid method of estimating risk of death fromComorbid disease for use in longitudinal studies and further work in larger populations is still required to refine the approach.
Journal ArticleDOI
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
TL;DR: It is concluded that the adapted comorbidity index will be useful in studies of disease outcome and resource use employing administrative databases.
Journal ArticleDOI
Comorbidity measures for use with administrative data.
TL;DR: The present method addresses some of the limitations of previous measures and produces an expanded set of comorbidities that easily is applied without further refinement to administrative data for a wide range of diseases.
Journal ArticleDOI
Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond
TL;DR: Two new measures, one based on integrated sensitivity and specificity and the other on reclassification tables, are introduced that offer incremental information over the AUC and are proposed to be considered in addition to the A UC when assessing the performance of newer biomarkers.